Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Takoma Park, Maryland Clinical Trials

A listing of Takoma Park, Maryland clinical trials actively recruiting patient volunteers.

RESULTS

Found (20) clinical trials

Chloroquine (CQ) and Azithromycin (AZ) Combination for Malaria Prophylaxis

This study is a Phase 2, open-label study of the combination of a single dose-level of AZ (Zithromax) plus CQ given weekly as a prophylaxis against CQ-resistant P falciparum in healthy adults. After signing informed consent, subjects will undergo screening procedures between Day -77 to Day -18. If enrolled, subjects ...

Phase

2.06 miles

Learn More »

CENTERA THV System in Intermediate Risk Patients Who Have Symptomatic Severe Calcific Aortic Stenosis Requiring Aortic Valve Replacement

A prospective, single-arm, controlled, multicenter study. Additional subjects may be enrolled in a bicuspid registry.

Phase N/A

3.88 miles

Learn More »

Identification of the Pre-exposure Prophylaxis (PrEP) Cascade for Women.

Pre-exposure prophylaxis (PrEP) with daily tenofovir-emtricitabine (TFV/FTC) reduces transmission of human immunodeficiency virus (HIV) by up to 92%, however PrEP is underutilized, especially in women. Women account for nearly 20% of new HIV diagnoses-- most via heterosexual transmission; African-American women and women of color are disproportionately affected. PrEP is recommended ...

Phase N/A

3.88 miles

Learn More »

Low-Fat Vegan Diet Versus a Mediterranean Diet on Body Weight

In a 36-week cross-over trial, overweight adults will consume a low-fat vegan diet and a Mediterranean diet in two separate 16-week phases. Changes in body weight will be the primary dependent variable. In addition, plasma lipid concentrations, insulin sensitivity, and postprandial metabolism will also be assessed and changes over time ...

Phase N/A

5.54 miles

Learn More »

A Study to Evaluate the Effect of of Albuterol Sulfate Inhalation Aerosol eq 90 mcg Base (Sun Pharmaceuticals Industries Limited)

To Evaluate the Pharmacodynamic Equivalence of Albuterol Sulfate Inhalation Aerosol, eq 90 mcg base (Sun Pharmaceuticals Industries Limited) to PROAIR HFA (albuterol sulfate) Inhalation Aerosol, eq 90 mcg base (Teva Respiratory, LLC) in Subjects With Stable, Mild Asthma

Phase

5.58 miles

Learn More »

Follow-Up Evaluation for Gene-Therapy-Related Delayed Adverse Events After Participation in Pediatric Oncology Branch Clinical Trials

Background Study subjects exposed to gene therapy interventions may be at risk for delayed or long term adverse consequences. The U.S. Food and Drug Administration (FDA) has issued Guidance for Industry: Gene Therapy Clinical Trials Observing Participants for Delayed Adverse Events, which outlines a framework to assess the risk of ...

Phase N/A

5.67 miles

Learn More »

Motivations Expectations and Decision-making of Sickle Cell Patients in Clinical Research

Clinical trials testing potentially curative interventions for sickle cell disease - such as gene therapy (GT) or peripheral blood stem cell transplantation (PBSCT) - have created a novel opportunity for patients with sickle cell disease, for whom standard therapies can only manage but not cure their conditions. But some of ...

Phase N/A

5.67 miles

Learn More »

The Genomic Ascertainment Cohort

The Genomic Ascertainment Cohort (TGAC) will be a large cohort of individuals with sequence data unselected for any specific phenotype. TGAC will enable the study of genetic disease while minimizing the bias of phenotypic ascertainment. TGAC will have a two-tiered system of participation. Tier 1 will be individuals who have ...

Phase N/A

5.67 miles

Learn More »

Response to the SHINGRIX Varicella Zoster Virus (VZV) Vaccine in Treatment Na(SqrRoot) ve Chronic Lymphocytic Leukemia (CLL) and CLL Treated With Bruton s-Tyrosine Kinase Inhibitor (BTK-I)

This study aims to determine the efficacy of the SHINGRIX varicella zoster virus (VZV) vaccine in chronic lymphocytic leukemia (CLL) patients that are treatment naive or receiving Bruton s-tyrosine kinase inhibitor (BTK-I) therapy. Key Eligibility Criteria: Diagnosis of CLL Cohort 1: Treatment naive CLL patients Cohort 2: Subjects must be ...

Phase

5.67 miles

Learn More »

QUILT-3.017: Study of NEO-201 in Solid Tumors

The experimental drug called NEO-201 (the "study drug") is a monoclonal antibody that is being tested and is not approved for use in the United States by the FDA. The primary purpose of this first in human targeted phase 1 open-label study with NEO-201 in subjects with advanced solid tumors ...

Phase

5.67 miles

Learn More »